According to the CCLE database, high SHARPIN mRNA expression is significantly associated (High vs Middle, p < 0.005; High vs Low, p < 0.05) with high GPX4 dependency in a bone and soft tissue sarcoma cohort (Figure 4K). This evidence concerns the gene GPX4 and soft tissue sarcoma.